Del Prato, Stefano http://orcid.org/0000-0002-5388-0270
Article History
Received: 11 December 2019
Accepted: 16 December 2019
First Online: 16 January 2020
Duality of interest
: The author has received research funding from AstraZeneca, Boehringer Ingelheim, Novartis Pharmaceuticals Co., and Merck Sharpe & Dohme; and is a consultant for or has received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Laboratoires Servier, Merck Sharp & Dohme, Novartis Pharmaceuticals Co., Novo Nordisk, Sanofi and Takeda.
Free to read: This content has been made available to all.